TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | -8 | -5 | -8 | 23 | -13 | 0 | -2 |
S | %wins | 100 | 100 | 100 | 0 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/13 20:02 | 11/19/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Repella Robert | DC | O | SVP,Chie | S.dm | -1,293 | 12.03 | 33 | -108 | -88 | 15 | D | 120 | 254 | 63 | 6 | 15 | 62 | 71 | -20 | -8 | -5 | -8 | 23 | -13 | 0 |
11/21/13 20:02 | 11/20/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Repella Robert | DC | O | SVP,Chie | M.dm | 483 | 4.92 | 33 | 98 | 15 | D | 120 | 254 | 63 | 6 | 15 | 62 | 71 | -20 | -8 | -5 | -8 | 23 | -13 | 0 | |
7/31/13 16:34 | 7/29/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Repella Robert | DC | O | SVP,Chie | M.d | 0 | 0.00 | 9 | 9 | 63 | 24 | D | 64 | 180 | 166 | 139 | 6 | 33 | 29 | 41 | 3 | -5 | -1 | -30 | 5 | 26 |
2/19/13 20:40 | 2/14/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Repella Robert | DC | O | SVP,Chei | M.d | 0 | 0.00 | 1 | 15 | New | 15 | D | -47 | -17 | -2 | 26 | 5 | -8 | 0 | 0 | -2 | -5 | -3 | 65 | 164 | 241 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |